Tag | Content |
---|
EnhancerAtlas ID | HS172-08602 |
Organism | Homo sapiens |
Tissue/cell | SGBS_adipocyte |
Coordinate | chr5:118658820-118661080 |
SNPs | Number: 1 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
NFE2L1 | MA0089.2 | chr5:118660143-118660158 | ACTGCTGAGTCACAG | - | 6.6 | Nfe2l2 | MA0150.2 | chr5:118660145-118660160 | TGCTGAGTCACAGGG | - | 6.27 | SPI1 | MA0080.4 | chr5:118660004-118660018 | AAAAAGAAGAAGTT | + | 6 | ZBTB18 | MA0698.1 | chr5:118661009-118661022 | CTTCCAGATGTTT | + | 6.46 |
|
| Number of super-enhancer constituents: 24 | ID | Coordinate | Tissue/cell |
SE_09224 | chr5:118656912-118660776 | CD14 | SE_10192 | chr5:118659774-118660551 | CD19_Primary | SE_13688 | chr5:118655632-118667935 | CD34_Primary_RO01536 | SE_14409 | chr5:118655163-118661212 | CD4_Memory_Primary_7pool | SE_17336 | chr5:118653398-118661142 | CD4p_CD25-_CD45RAp_Naive | SE_17778 | chr5:118653572-118683948 | CD4p_CD25-_CD45ROp_Memory | SE_18242 | chr5:118653598-118687006 | CD4p_CD25-_Il17-_PMAstim_Th | SE_19112 | chr5:118655498-118661144 | CD4p_CD25-_Il17p_PMAstim_Th17 | SE_20766 | chr5:118655352-118660835 | CD8_Memory_7pool | SE_22350 | chr5:118656822-118660581 | CD8_primiary | SE_25388 | chr5:118656890-118660637 | DND41 | SE_30942 | chr5:118657754-118660768 | Fetal_Thymus | SE_32471 | chr5:118657455-118660784 | GM12878 | SE_39376 | chr5:118659293-118659823 | Jurkat | SE_39914 | chr5:118654754-118661140 | K562 | SE_49946 | chr5:118656901-118659864 | RPMI-8402 | SE_58310 | chr5:118603634-118704575 | Ly1 | SE_59637 | chr5:118603673-118697862 | Ly4 | SE_60461 | chr5:118639775-118703145 | DHL6 | SE_61019 | chr5:118608552-118705688 | HBL1 | SE_61555 | chr5:118642263-118726869 | Toledo | SE_62209 | chr5:118603018-118707327 | Tonsil | SE_64429 | chr5:118657596-118661290 | NHEK | SE_66260 | chr5:118659293-118659823 | Jurkat |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr5 | 118659320 | 118659663 | chr5 | 118659671 | 118660476 |
|
Enhancer Sequence | TGCTGCCATC TCTTTCCTAG GTTACTTAAA GGGCAGTTGC ACCCCCTACA CTTTCTCCAG 60 TCTAACATCC TATGCTGCTA TTGGCCTCAT AAAATGTCCA TCTGATTGCA TCATCCTTTG 120 CTTAAAATGC CTCATTAGAG TTTTGATAAA ATCTAAACTT TTTAACAGGG CTTATAAGAT 180 CCTTAATAAC CTGTTCCCAA GCTGGCTGCA TTTCTTGGAG TTTCTCGGAA ATATCTGCCT 240 CCCTCAAGCA CATTCCCACC CCACCCTGCA TACATACACA TCTCTGGCCA CTTGTTTGTC 300 ATTTACCCTA GAGTCTAACA TAGGGCACAG TAAGGCCTCA ATAAATATTT GTTAAATAAA 360 GGTAGGAAGG CAGTGGTCCT GGATTTTAAT TGTATGTCCT CACATTTTAA TTTAATTTAC 420 CTTAAAAATG TAAATGATTC CAGAGTCAAA AGTTGCTGTT TTGTTTTATA GTGCTCTGTA 480 TGTTTCCCTC CACTCTGTAG TTTCCAGAGG GTTATTAAAA ATGGACTAAA AGAAGCATGT 540 GGGCTTCTGT TAGCAAATCA GTTGTAATCT GTGTTCTTTG GCTGAGTGCT GAGCTTAGGA 600 GGCTGCCAGA TGGGGACACA GGAACCAAAT CATCTTTGCT TCCCAGTGGG GAACAGGGGC 660 ATAAATTGGC TGAATGGGCT TCTGCAGTAA AACTCCTTCA ATTTGAGCTT GTGTAAGCCA 720 GGATCAAAAT ACCTGAGACT TGTTGAGACT TGTCTAGAAT GTTTGTTAAA CTTTCAAACC 780 TGTTTGGGAA GAAGGCTTGG AACAACAGTG GGTTTGGGTC TTGTGAAGTA AATCTTATTT 840 AAAGGAAATA GACAAAAGCT TAATCATGTT TAATTTGTAA CATTATAGGT AAGACTGTTG 900 GTTGCTGTTG TAATGACTCT AAAAAAGAAT AGAGAATATT TTTTTCCTTA GAAGTTCCAG 960 GTTCAATGAT GAAACCCCAT CTCTACCAAA AATTCAAAAA TTAGCCAGGT GTGTTGGCCA 1020 GTGTCTATAA TCCCAGCTAC TCGAGAGGCT GAGGCAGGAA AATCACCTGA ACCCAGGAGG 1080 TGGAGGCTGC AGTGAGCCGA GATCGCGCCA CTGCACTCCA GCCTGAGCCA CAAAGCAAGA 1140 CGCCATCTCA AAAAAAAAAA AAAAAAAAAA AAAAAAAAAA AAAAAAAAAG AAGAAGTTCC 1200 AAGTTCAACA TTCCCAACTT CCCCCTCGGG GCTGGGAGCT CCTGGGTGAG GTTTCTAAGT 1260 CTCCATCCTC TCAGAACTCC TATCTTTAAC TTCTTCGTGC ATGGATCAGA GGGGCCTCCA 1320 GTCACTGCTG AGTCACAGGG ATAAGCAAAA AGGGAATGAC ACACTTCCTG CCCCAAGTTC 1380 TAGGGAGTTT TTATGGTTTG TTTTTCTGTT TCGCTTTGAA AATTCCCTGA AAAGACAGAA 1440 GATTGCCCCA GCCGCCTCCT GATTGGCAGC CTCTATTTAT TTATATGATT TCATGGGATA 1500 TCCTCTCTGC TATGCCTTGT AACTCACAGG GTTTTTGAAA CCTTTTTTCC TTATCACAGC 1560 AGTATTACAT GTTTGTGTAG TGTATTTATC AACTACAATT TGACCAATAA AAAAAAAAGA 1620 GGCACTCCTT ATTGTCACTA CCCAGAAAAA AATATATTGT GCATATCATC ATTCCAGGCG 1680 CTTTTCTGTG TGCTTATAGT TTTCTCTTTA AAAATTATAT ATGGCTTAAT ATAATTTCTT 1740 TGCTTTTATA TATTGTTTTG TAGCCTTTGT GAAGAGTTCT CATGTTATTA ATACTCTGCA 1800 AGATCGGTTT TAAAGATTGC ATTACTGGCC AGCCGCAGTG GCTCACACCT GTAATCCTAG 1860 CCCTTTGGGA GGCTGAGGCA GGAGAATTGC TTGAGGCCAA TGGTTCAAGA CCAACTTGGC 1920 CAACATAGCA AGACCCTGTC TCTTAAAAAA TAAAAAATAA AAAAAAAAAG ACTGCATTAC 1980 ATGCCATATA TGGATGTGCC ATAATTTACT TAATCAGTCC CCATGTGGAT AGTTAGGCTC 2040 TAAAAGTTTT CATATGGGGT CATTGTCATA ACCCCGCGCA GTTTCCTTGC ACTTGTCCAC 2100 ACTTCTGTCT ATTTCATGGG ATGTATTCCT GTAAGTGGTT CAAAGGGCCT GTGGAGTTTT 2160 AAGGTTTTTG ATCTTTATTG TCACTTTGCC TTCCAGATGT TTGTCCTGTT TTACATTCCT 2220 GTCATATAAT ATAAACTCCT TACCATGTCC TATATGGTCT 2260
|